Tenaya Therapeutics, Inc. (TNYA) Tops Q3 EPS by 8c

Tenaya Therapeutics, Inc. (NASDAQ: TNYA) reported Q3 EPS of ($0.39), $0.08 better than the analyst estimate of ($0.47).

For earnings history and earnings-related data on Tenaya Therapeutics, Inc. (TNYA) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• JPMorgan Upgrades Whitehaven Coal Ltd. (WHC:AU) (WHITF) to Overweight
• Goldman Sachs Downgrades Vonovia SE (VNA:DR) (VNNVF) to Neutral